Tag

Glaucoma

All articles tagged with #glaucoma

Ophthalmologist warns seven everyday habits may accelerate vision loss
health4 days ago

Ophthalmologist warns seven everyday habits may accelerate vision loss

Dr. Douglas Lazzaro, an ophthalmology professor at NYU Langone Health, identified seven common daily habits that may silently damage eye health. These include failing to wear sunglasses, reading in dim light, poor diet, dehydration, inadequate sleep, rubbing the eyes, and delaying routine eye exams. Lazzaro noted that cataracts are appearing five to 10 years earlier than three decades ago, potentially linked to ultraviolet exposure. He emphasized that glaucoma, often called the 'silent thief of sight,' requires annual screening for early detection. Other risks include keratoconus from eye rubbing and vascular issues linked to sleep apnea. Lazzaro advised that while genetics and aging drive many eye diseases, modifying these lifestyle factors can help slow progression and protect vision.

Ophthalmologist Identifies Seven Daily Habits Accelerating Age-Related Vision Loss
health5 days ago

Ophthalmologist Identifies Seven Daily Habits Accelerating Age-Related Vision Loss

Dr. Douglas Lazzaro of NYU Langone Health identifies seven common lifestyle habits that may accelerate age-related eye conditions like glaucoma and cataracts. These include unprotected sun exposure, reading in poor lighting, poor diet, dehydration, insufficient sleep, eye rubbing, and delaying routine eye exams. Lazzaro notes that cataracts are appearing five to 10 years earlier than three decades ago, potentially linked to ultraviolet exposure. He emphasizes that annual ophthalmologic exams are critical for detecting silent conditions like glaucoma, which often presents no symptoms until significant damage has occurred.

Big study ties Cialis for enlarged prostate to a modest glaucoma risk; eye exams advised
health26 days ago

Big study ties Cialis for enlarged prostate to a modest glaucoma risk; eye exams advised

An observational study of 73,854 men suggests daily tadalafil (Cialis) for enlarged prostate is associated with a small increase in glaucoma, ocular hypertension, and related treatment initiation over five years (3.93% vs 3.16%, about 8 extra cases per 1,000 men). The study can show only association, not causation, and most participants were White, but the finding warrants routine eye checks—especially for those with glaucoma risk factors—rather than stopping the medication. Medicare coverage details and exam logistics are provided, but the key takeaway is to schedule annual dilated eye exams and discuss risks with your doctor rather than discontinue therapy.

Regular Cialis Use Linked to Modest Glaucoma Risk, Study Finds
health29 days ago

Regular Cialis Use Linked to Modest Glaucoma Risk, Study Finds

An observational study of 36,927 men aged 40+ found that regular tadalafil use over five years was associated with a higher glaucoma diagnosis rate (3.93% vs 3.16% in non-users), a 22% relative increase with an absolute difference of about 0.77 percentage points. The study cannot prove causation, and researchers note that the overall risk remains small; patients using tadalafil long-term should discuss eye monitoring with a clinician rather than stopping the medication.

Big Study Finds Long-Term Cialis Use May Increase Glaucoma Risk
health1 month ago

Big Study Finds Long-Term Cialis Use May Increase Glaucoma Risk

A large observational study of about 74,000 men aged 40+ with lower urinary tract symptoms found long-term tadalafil use was associated with higher risks of glaucoma (22%), elevated intraocular pressure (32%), and primary open-angle glaucoma (33%) over up to five years, though causation cannot be established. The findings suggest regular eye monitoring for long-term Cialis users, especially those with glaucoma risk factors; patients should not stop the medication without medical advice.

Large study links tadalafil use to higher glaucoma risk
health1 month ago

Large study links tadalafil use to higher glaucoma risk

An observational study of about 74,000 men aged 40+ over up to five years found tadalafil (Cialis) use for erectile dysfunction and enlarged-prostate symptoms was associated with a 22% higher risk of glaucoma, a 32% higher risk of elevated intraocular pressure, and a 33% higher risk of primary open-angle glaucoma versus nonusers. The study, published in the British Journal of Ophthalmology, cannot prove causation; researchers urge regular baseline eye exams for long‑term users, especially those with glaucoma risk factors.

Popular ED Drug Linked to Small Increase in Glaucoma Risk
health1 month ago

Popular ED Drug Linked to Small Increase in Glaucoma Risk

Taiwanese study of nearly 37,000 men over 40 found daily tadalafil use for urinary symptoms associated with a 22% higher risk of developing glaucoma over five years versus non-users, and a higher risk of ocular hypertension. Absolute glaucoma incidence rose from 3.16% to 3.93% among users (about 0.77 percentage points). Although the overall risk remains small, doctors should monitor vision in patients prescribed PDE5 inhibitors, especially those with glaucoma risk factors, and more research is needed to understand the mechanism.

ED Drug Cialis Linked to Higher Glaucoma Risk, Study Finds
health1 month ago

ED Drug Cialis Linked to Higher Glaucoma Risk, Study Finds

A large observational study of about 74,000 men aged 40+ found that tadalafil (Cialis), used for erectile dysfunction and urinary symptoms, was associated with a 22% higher risk of glaucoma (33% for primary open-angle glaucoma) and a 32% higher risk of ocular hypertension. The researchers caution that the design cannot prove causation, but regular eye exams may be advisable for users, especially those with predispositions, given widespread tadalafil use (millions of prescriptions in 2024).

health1 month ago

Long-Term PDE5 Inhibitor Use Tied to Increased Glaucoma Risk

A large observational study of 73,854 men found that long-term tadalafil use for urinary symptoms was associated with higher odds of glaucoma (22%), ocular hypertension (32%), and starting glaucoma treatment (33%) over five years, compared with non-users. While the study cannot prove causation and has limitations (e.g., limited ethnic diversity), researchers advise baseline eye exams and regular eye monitoring for long-term users, especially those with glaucoma risk factors.

Epigenetic Rejuvenation in the Eye Sets Stage for Reversing Blindness
science3 months ago

Epigenetic Rejuvenation in the Eye Sets Stage for Reversing Blindness

Scientists report that epigenetic reprogramming to revive youthful cellular memory in aging eye cells has reached humans, with the first patient treated in a Phase 1 trial for glaucoma and other optic neuropathies. The approach could someday restore some lost vision, but safety, delivery, and how durable the effects are remain major hurdles before it becomes a widely available therapy.

First-in-Human Gene Therapy Aims to Rewind Cellular Aging in Glaucoma
science3 months ago

First-in-Human Gene Therapy Aims to Rewind Cellular Aging in Glaucoma

A Life Biosciences Phase 1 trial is testing ER-100, a gene therapy designed to reset the aging clock in eye cells using OSK (OCT4, SOX2, KLF4) to potentially restore vision in open-angle glaucoma. Early preclinical data suggest epigenetic restoration can improve cellular function, but the approach carries safety risks, including cancer, and it remains uncertain whether translating this to humans will succeed or be safe.

First Human Trial Tests Rejuvenation of Aging Eye Cells for Glaucoma
science3 months ago

First Human Trial Tests Rejuvenation of Aging Eye Cells for Glaucoma

Scientists have begun the first human trial of partial cellular reprogramming to nudge aging eye cells toward a younger state in hopes of regenerating optic nerve neurons to treat glaucoma. The study by Life Biosciences treated the first participant and plans to enroll up to 12 total; this is an early, experimental approach—not a lifespans therapy—with cancer risk as a key concern and no results yet.

First human trial tests partial reprogramming to reverse aging in glaucoma
science3 months ago

First human trial tests partial reprogramming to reverse aging in glaucoma

Scientists have treated the first participant in an early-stage clinical trial testing partial cellular reprogramming to make aging cells act younger, aiming to regenerate optic nerve neurons in glaucoma. While promising, the approach is experimental, enrolling up to 12 participants, with potential cancer risk, and is not a universal anti-aging therapy.

Aging Eyes: Simple Steps to Prevent Four Common Vision Threats
health3 months ago

Aging Eyes: Simple Steps to Prevent Four Common Vision Threats

As people age, four common eye conditions—diabetic retinopathy, glaucoma, cataracts, and macular degeneration—rise in risk, but most vision loss can be prevented or delayed through regular eye exams (starting after age 45 or when diabetes is diagnosed), a healthy lifestyle, controlling blood pressure, diabetes, and cholesterol, protecting eyes from UV light, and timely treatments such as cataract surgery or glaucoma management; support and rehabilitation options are available for those with visual impairment.